open access
Journal of Drug Discovery and Research

Peer-Reviewed Quarterly (Four issues per year) ISSN: 3107-720X

Article Processing Timeline

2-7 Days
Initial Quality & Plagiarism Check
15 Days
Peer Review Feedback
80-85%
Acceptance Rate (after peer review)
30-45 Days
Total article processing time

Editorial Board

Amgad M Rabie

(Editor-in-Chief)
Amgad M Rabie (PhD)

Senior Pharmacist
Department of Drug Discovery and Clinical Research, Dikernis General Hospital
Egypt
Pedro Fonte

(Editor-in-Chief) [Profile Link]
Pedro Fonte (PhD)

Assistant Professor
Faculty of Sciences and Technology, University of Algarve
Portugal
Duo Liu

(Editor-Member) [Profile Link]
Duo Liu (Ph.D)

Professor
Department of Pharmacy, Harbin Medical University Cancer Hospital
China
Chan Siok Yee

(Editor-Member) [Profile Link]
Chan Siok Yee (PhD)

Associate Professor
Department of Pharmaceutical Science, Universiti Sains Malaysia
Malaysia
Narsimha Mamidi

(Editor-Member) [Profile Link]
Narsimha Mamidi (PhD)

Staff Scientist
Department of Pharmacy, University of Wisconsin
United States
Ziyaul Haque Shakeel Ahmad

(Editor-Member) [Profile Link]
Ziyaul Haque Shakeel Ahmad (PhD)

Assistant Professor
Department of Pharmaceutical Chemistry, Anjuman-I-Islam Kalsekar Technical Campus
India
Shazia Usmani

(Editor-Member) [Profile Link]
Shazia Usmani (PhD)

Professor
Department of Pharmacy, Integral University
India
Fawzy A Saad

(Editor-Member)
Fawzy A Saad (Ph.D.)

Chief Executive Officer
Department of Drug Discovery, Saad Pharmaceuticals
Estonia
Yasameen Hmeed Jasim AL-Daraji

(Editor-Member)
Yasameen Hmeed Jasim AL-Daraji (PhD)

Lecturer
Department of Applied Chemistry, University of Samarra
Iraq

About the Journal

Overview

The Journal of Drug Discovery and Research is a peer-reviewed, open-access publication dedicated to advancing scientific knowledge in all areas of drug development and therapeutic innovation. The journal serves as a dynamic platform for researchers, scientists, and healthcare professionals to share original research articles, comprehensive reviews, case studies, and short communications that explore the discovery, design, development, and evaluation of novel drugs.

With a focus on both basic and applied aspects of drug discovery, the journal welcomes contributions across a broad spectrum of disciplines, including medicinal chemistry, pharmacology, toxicology, molecular modeling, high-throughput screening, pharmacokinetics, and drug delivery systems. Emphasizing innovation and translational research, it also highlights studies that bridge the gap between laboratory findings and clinical application.

Our mission is to promote scientific excellence and facilitate the exchange of knowledge that can drive future breakthroughs in drug discovery and therapeutic strategies. By offering timely publication and global visibility, the Journal of Drug Discovery and Research supports the ongoing efforts of the scientific community in improving human health.

Aim and Scope

The Journal of Drug Discovery and Research publishes original research articles, reviews, short communications, case studies, and technical perspectives that explore all facets of drug discovery, pharmaceutical innovation, and therapeutic development. We welcome submissions in a variety of thematic areas, including (but not limited to):

Medicinal Chemistry & Drug Design

  • Rational drug design, structure–activity relationships (SAR), and lead optimization
  • Synthesis, characterization, and evaluation of novel bioactive compounds
  • Natural products, synthetic molecules, and peptide-based therapeutics
  • Chemical biology, target identification, and mechanistic studies

Computational & AI-Driven Drug Discovery

  • Molecular docking, virtual screening, pharmacophore modeling, and QSAR analyses
  • Molecular dynamics simulations and in silico ADMET predictions
  • AI/ML-enabled hit identification, de novo drug design, and systems-level modeling

Pharmacology, Toxicology & ADME Studies

  • In vitro and in vivo pharmacological evaluations of drug candidates
  • Toxicity studies, safety profiling, and dose-response assessments
  • Pharmacokinetics (PK), pharmacodynamics (PD), and drug–drug interaction analyses
  • Biomarker discovery, target validation, and mechanistic pharmacology

Drug Delivery Systems & Nanopharmaceuticals

  • Nanocarriers, liposomes, polymeric nanoparticles, and targeted delivery platforms
  • Controlled-release systems, transdermal, mucosal, and inhalation delivery technologies
  • Biocompatibility, stability, and performance of advanced delivery systems

Biopharmaceuticals, Biotechnology & Advanced Therapeutics

  • Monoclonal antibodies, recombinant proteins, and biosimilars
  • Gene therapy, RNA-based therapeutics, and cellular therapies
  • Immunotherapy, vaccine development, and engineered biologics

Pharmaceutical Analysis & Quality Assurance

  • Analytical method development, validation, and impurity profiling
  • Chromatographic, spectroscopic, and mass spectrometric characterization
  • Stability studies, quality control, and regulatory compliance
  • Analytical approaches for complex and biological formulations

Clinical Research & Translational Drug Development

  • Preclinical-to-clinical translation strategies
  • Early-phase clinical trials, dose optimization, and therapeutic index assessment
  • Precision medicine, personalized therapies, and biomarker-driven clinical studies
  • Pharmacovigilance, real-world evidence, and post-marketing evaluations

Natural Products, Traditional Medicines & Bioactive Compounds

  • Isolation, characterization, and pharmacological assessment of natural products
  • Ethnopharmacology and traditional medicinal systems
  • Standardization, quality, and mechanistic insights into natural therapeutics

Emerging, Interdisciplinary & Applied Pharmaceutical Sciences

  • Drug repurposing, polypharmacology, and multi-target therapeutics
  • Industrial drug development, formulation technologies, and scale-up innovations
  • Regulatory science, policy, and ethics in drug research and development
  • Intellectual property, commercialization, and technology transfer

Editorial and Peer-Review Policy

Journal of Drug Discovery and Research adheres to a strict single-blind peer-review process to maintain the quality, integrity, and scientific validity of all published work.

Key features include:

  • Each manuscript is reviewed by at least two independent experts in the field, along with an academic editor.
  • Reviewers know who the authors are, but the authors remain unaware of the reviewer's identities.
  • The evaluations emphasize scientific merit, originality, methodological rigor, ethical compliance, and how well the work fits within the journal's scope.
  • Every submission goes through plagiarism checks and ethical compliance assessments before the review process begins.
  • The final decision on publication is based on the reviewer's recommendations and the editor's evaluation.

Publication Frequency & Format

Journal of Drug Discovery and Research publishes three times a year, adhering to a tri-annual schedule. Accepted articles are made available online in both HTML and PDF formats, ensuring that scholarly work is accessible and disseminated promptly.

Open Access Policy

Journal of Drug Discovery and Research operates under a fully open access model. This means all published content is freely accessible to readers around the globe, without any subscription or paywall. Authors maintain the copyright to their work, and the content is shared under an appropriate open-access license.

Indexing & Archiving

Journal of Drug Discovery and Research is dedicated to upholding high standards with the goal of being included in reputable scientific indexing and abstracting services. The journal also ensures long-term digital preservation through recognized archives and repositories, guaranteeing permanent access and discoverability.

Manuscript Submission

Authors are encouraged to submit their manuscripts through the journal's Online Submission System (Submit Manuscript) or by emailing them directly to the Editorial Office at support@globalmeetx.com.

Manuscripts must adhere to the journal's author guidelines regarding structure, formatting, referencing style, ethical approvals, and necessary disclosures (such as conflicts of interest and funding).

Publication Ethics & Integrity

Journal of Drug Discovery and Research follows internationally recognized standards for publication ethics and research integrity, which include (but are not limited to):

  • Make sure you have ethical approval.
  • Ensure informed consent and guarantee confidentiality.
  • Declare any conflicts of interest.
  • Be transparent about data availability.
  • Clarify authorship criteria and the roles of contributors.
  • Conduct anti-plagiarism checks.
  • Have a clear policy for retraction and correction.

JOURNAL PARTICULARS

Title Journal of Drug Discovery and Research
Frequency Quarterly (Four issues per year)
ISSN 3107-720X
Publisher Name Globalmeetx Publishing
Publisher Address Radha Residency, 4th Floor, Sai Priya Gardens, Madhurawada, 530041, Andhra Pradesh, India.
Starting Year 2025
Subject Medical Sciences
Language English
Publication Format Online
Email support@globalmeetx.com
Mobile No (+91) 9177731784

Journals Indexed In

CrossRef DOAJ Google Scholar
OAJI PubMed ResearchBib
Sindexs WorldCat CrossRef

Submit Manuscript

Submit manuscript at Online Submission System or send as an e-mail attachment to the Editorial Office at support@globalmeetx.com

Peer Review Process